SEARCH

SEARCH BY CITATION

References

  • Adachi, Y., M. Okazaki, N. Ohno, and T. Yadomae. 1994. Enhancement of cytokine production by macrophages stimulated with (1–>3)-b-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol. Pharm. Bull. 17(12):15541560.
  • Ahren, I. L., D. L. Williams, P. J. Rice, A. Forsgren, and K. Riesbeck. 2001. The importance of a b-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J. Infect. Dis. 184(2):150158.
  • Akramiene, D., A. Kondrotas, J. Didziapetriene, and E. Kevelaitis. 2007. Effects of beta-glucans on the immune system. Medicina (Kaunas) 43(8):597606.
  • Arbes, S. J. Jr, P. J. Gergen, L. Elliott, and D. C. Zeldin. 2005. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J. Allergy Clin. Immunol. 116(2):377383.
  • Austin, J. B., B. Kaur, H. R. Anderson, M. Burr, L. S. Harkins, D. P. Strachan, et al. 1999. Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood). Arch. Dis. Child. 81(3):225230.
  • Babineau, T. J., A. Hackford, A. Kenler, B. Bistrian, R. A. Forse, P. G. Fairchild, et al. 1994a. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch. Surg. 129(11):12041210.
  • Babineau, T. J., P. Marcello, W. Swails, A. Kenler, B. Bistrian, and R. A. Forse. 1994b. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann. Surg. 220(5):601609.
  • Bell, S., V. M. Goldman, B. R. Bistrian, A. H. Arnold, G. Ostroff, and R. A. Forse. 1999. Effect of β-glucan from oats and yeast on serum lipids. Crit. Rev. Food Sci. Nutr. 39(2):189202.
  • Biagini, R. E., B. A. MacKenzie, D. L. Sammons, J. P. Smith, E. F. Krieg, S. A. Robertson, et al. 2006. Latex specific IgE: performance characteristics of the IMMULITE 2000 3gAllergy assay compared with skin testing. Ann. Allergy Asthma Immunol. 97(2):196202.
  • Boulet, L. P., H. Turcotte, C. Laprise, C. Lavertu, P. M. Bedard, A. Lavoie, et al. 1997. Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma. Clin. Exp. Allergy 27(1):5259.
  • Bousquet, J., H. Dhivert, and F. B. Michel. 1994. Current trends in the management of allergic diseases. Allergy 49(18 Suppl):3136.
  • Bousquet, J., P. van Cauwenberge, and N. Khaltaev. 2001. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108(5 Suppl):S147S334.
  • Bousquet, P. J., C. Combescure, F. Neukirch, J. M. Klossek, H. Mechin, J. P. Daures, et al. 2007. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 62(4):367372.
  • Browder, W., D. Williams, H. Pretus, G. Olivero, F. Enrichens, P. Mao, et al. 1990. Beneficial effect of enhanced macrophage function in the trauma patient. Ann. Surg. 211(5):605612.
  • Brown, G. D. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6(1):3343.
  • Brown, G. D., and S. Gordon. 2001. Immune recognition. A new receptor for b-glucans. Nature 413(6851):3637.
  • Brown, G. D., and S. Gordon. 2005. Immune recognition of fungal β-glucans. Cell. Microbiol. 7(4):471479.
  • Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, et al. 2002. Dectin-1 is a major b-glucan receptor on macrophages. J. Exp. Med. 196(3):407412.
  • Brown, G. D., J. Herre, D. L. Williams, J. A. Willment, A. S. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197(9):11191124.
  • Bukantz, S. C., and R. F. Lockey. 2004. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clin. Allergy Immunol. 18:711727.
  • Chen, J., and R. Seviour. 2007. Medicinal importance of fungal b-(1–>3), (1–>6)-glucans. Mycol. Res. 111(Pt 6):635652.
  • Cheung, N. K., S. Modak, A. Vickers, and B. Knuckles. 2002. Orally administered b-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunother. 51(10):557564.
  • Creticos, P. S., J. T. Schroeder, R. G. Hamilton, S. L. Balcer-Whaley, A. P. Khattignavong, R. Lindblad, et al. 2006. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355(14):14451455.
  • Damiani, V., C. M. Di, G. Grappasonni, D. R. Di, and P. Dominici. 2011. Efficacy of a new medical device based on colloidal silver and carbossimetyl beta glucan in treatment of upper airways disease in children. Minerva Pediatr. 63(5):347354.
  • Delatte, S. J., J. Evans, A. Hebra, W. Adamson, H. B. Othersen, and E. P. Tagge. 2001. Effectiveness of b-glucan collagen for treatment of partial-thickness burns in children. J. Pediatr. Surg. 36(1):113118.
  • Dellinger, E. P., T. J. Babineau, P. Bleicher, A. B. Kaiser, G. B. Seibert, R. G. Postier, et al. 1999. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch. Surg. 134(9):977983.
  • Di Carlo, F. J., and J. V. Fiore. 1958. On the composition of zymosan. Science 127(3301):756757.
  • Douwes, J. 2005. (1–>3)-b-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 15(3):160169.
  • Driscoll, M., R. Hansen, C. Ding, D. E. Cramer, and J. Yan. 2009. Therapeutic potential of various b-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biol. Ther. 8(3):218225.
  • Du Buske, L. M., C. J. Ling, and A. L. Sheffer. 1992. Special problems regarding allergen immunotherapy. Immunol. Allergy Clin. North Am. 12:145175.
  • Feldman, S., H. I. Schwartz, D. S. Kalman, A. Mayers, H. M. Kohrman, R. Clemens, et al. 2009. Randomized phase II clinical trials of Wellmune WGP® for immune support during cold and flu season. J. Appl. Res. 9(1–2):3042.
  • de Felippe, J. J.,daRocha e Silva Junior, F. M. Maciel, A. M. Soares, and NF Mendes 1993. Infection prevention in patients with severe multiple trauma with the immunomodulator b 1–3 polyglucose (glucan). Surg. Gynecol. Obstet. 177(4):383388.
  • Frenz, D. A., M. A. Palmer, J. M. Hokanson, and R. T. Scamehorn. 1995. Seasonal characteristics of ragweed pollen dispersal in the United States. Ann. Allergy Asthma Immunol. 75(5):417422.
  • Hahn, P. Y., S. E. Evans, T. J. Kottom, J. E. Standing, R. E. Pagano, and A. H. Limper. 2003. Pneumocystis carinii cell wall b-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J. Biol. Chem. 278(3):20432050.
  • Hallen, H., P. Djupesland, J. Kramer, K. Toll, and P. Graf. 2001. Evaluation of a new method for assessing symptoms. ORL J. Otorhinolaryngol. Relat. Spec. 63(2):9295.
  • Hays, R. D., C. D. Sherbourne, and R. M. Mazel. 1993. 36-Item Health Survey 1.0. Health Econ. 2(3):217227.
  • Hazama, S., S. Watanabe, M. Ohashi, M. Yagi, M. Suzuki, K. Matsuda, et al. 2009. Efficacy of orally administered superfine dispersed lentinan (b-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res. 29(7):26112617.
  • Holgate, S. T. 1999. The epidemic of allergy and asthma. Nature 402(6760 Suppl):B2B4.
  • Hong, F., J. Yan, J. T. Baran, D. J. Allendorf, R. D. Hansen, G. R. Ostroff, et al. 2004. Mechanism by which orally administered b-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173(2):797806.
  • Hornblow, A. R., and M. A. Kidson. 1976. The visual analogue scale for anxiety: a validation study. Aust. N. Z. J. Psychiatry 10(4):339341.
  • Huang, S. K., H. Q. Xiao, J. Kleine-Tebbe, G. Paciotti, D. G. Marsh, L. M. Lichtenstein, et al. 1995. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 155(5):26882694.
  • Ikewaki, N., N. Fujii, T. Onaka, S. Ikewaki, and H. Inoko. 2007. Immunological actions of Sophy b-glucan (b-1,3–1,6 glucan), currently available commercially as a health food supplement. Microbiol. Immunol. 51(9):861873.
  • Biothera Inc.. 2008. GRAS Notice for Yeast Beta-Glucan [GRN 239]. Biothera, Inc., Eagan, MN.
  • Iossifova, Y. Y., T. Reponen, D. I. Bernstein, L. Levin, H. Kalra, P. Campo, et al. 2007. House dust (1–3)-b-D-glucan and wheezing in infants. Allergy 62(5):504513.
  • Juniper, E. F., and G. H. Guyatt. 1991. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy 21(1):7783.
  • Juniper, E. F., D. G. Willms, G. H. Guyatt, and P. J. Ferrie. 1992. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis. CMAJ 147(6):887892.
  • Juniper, E. F., G. H. Guyatt, L. E. Griffith, and P. J. Ferrie. 1996. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J. Allergy Clin. Immunol. 98(4):843845.
  • Kataoka, H., T. Shimura, T. Mizoshita, E. Kubota, Y. Mori, T. Mizushima, et al. 2009. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life. Hepatogastroenterology 56(90):547550.
  • Kay, A. B. 2001a. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344(1):3037.
  • Kay, A. B. 2001b. Allergy and allergic diseases. Second of two parts. N. Engl. J. Med. 344(2):109113.
  • Kim, H. S., J. T. Hong, Y. Kim, and S. B. Han. 2011. Stimulatory effect of b-glucans on immune cells. Immune Netw. 11(4):191195.
  • Kirmaz, C., P. Bayrak, O. Yilmaz, and H. Yuksel. 2005. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study. Eur. Cytokine Netw. 16(2):128134.
  • Kougias, P., D. Wei, P. J. Rice, H. E. Ensley, J. Kalbfleisch, D. L. Williams, et al. 2001. Normal human fibroblasts express pattern recognition receptors for fungal (1–>3)-b-D-glucans. Infect. Immun. 69(6):39333938.
  • Kurashige, S., Y. Akuzawa, and F. Endo. 1997. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol. Immunotoxicol. 19(2):175183.
  • Ladanyi, A., J. Timar, and K. Lapis. 1993. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol. Immunother. 36(2):123126.
  • Lebron, F., R. Vassallo, V. Puri, and A. H. Limper. 2003. Pneumocystis carinii cell wall b-glucans initiate macrophage inflammatory responses through NF-kB activation. J. Biol. Chem. 278(27):2500125008.
  • Lehne, G., B. Haneberg, P. Gaustad, P. W. Johansen, H. Preus, and T. G. Abrahamsen. 2005. Oral administration of a new soluble branched b-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin. Exp. Immunol. 143(1):6569.
  • Leplege, A., M. Mesbah, and P. Marquis. 1995. Preliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1). Rev. Epidemiol. Sante Publique 43(4):371379.
  • Leynaert, B., C. Neukirch, R. Liard, J. Bousquet, and F. Neukirch. 2000. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am. J. Respir. Crit. Care Med. 162(4 Pt 1):13911396.
  • Li, B., D. J. Allendorf, R. Hansen, J. Marroquin, C. Ding, D. E. Cramer, et al. 2006. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J Immunol 177(3):16611669.
  • Linder, A. 1988. Symptom scores as measures of the severity of rhinitis. Clin Allergy 18(1):2937.
  • Lockey, R. F., L. M. Benedict, P. C. Turkeltaub, and S. C. Bukantz. 1987. Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 79(4):660677.
  • Lowe, E. P., D. Wei, P. J. Rice, C. Li, J. Kalbfleisch, I. W. Browder, et al. 2002. Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor kB activation and interleukin 8 production. Winner of the Best Paper Award from the Gold Medal Forum. Am. Surg. 68(6):508517.
  • McCann, F., E. Carmona, V. Puri, R. E. Pagano, and A. H. Limper. 2005. Macrophage internalization of fungal b-glucans is not necessary for initiation of related inflammatory responses. Infect. Immun. 73(10):63406349.
  • McHorney, C. A., and J. E. Jr Ware. 1994. Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 32(1):4066.
  • McNair, D., M. Loor, and L. Droppleman. 1971. Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, CA.
  • McNair, D., J. Heuchert, and E. Shilony. 2003. Profile of Mood States Bibliography 1964–2002. Available from: www.mhs.com [cited 18 December 2008].
  • Meltzer, E. O. 2001. Quality of life in adults and children with allergic rhinitis. J. Allergy Clin. Immunol. 108(1 Suppl):S45S53.
  • Murphy, E. A., J. M. Davis, and M. D. Carmichael. 2010. Immune modulating effects of β-glucan. Curr. Opin. Clin. Nutr. Metab. Care 13(6):656661.
  • Nakano, H., K. Namatame, H. Nemoto, H. Motohashi, K. Nishiyama, and K. Kumada. 1999. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology 46(28):26622668.
  • Nathan, R. A. 2003. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann. Allergy Asthma Immunol. 90(2):182190.
  • Nathan, R. A. 2007. The burden of allergic rhinitis. Allergy Asthma Proc. 28(1):39.
  • National Institute of Allergy and Infectious Diseases. 2003. Airborne allergens: something in the air. National Institutes of Health,Bethesda, MD: Report No.: NIH Publication No. 03-7045.
  • Nicolosi, R., S. J. Bell, B. R. Bistrian, I. Greenberg, R. A. Forse, and G. L. Blackburn. 1999. Plasma lipid changes after supplementation with b-glucan fiber from yeast. Am. J. Clin. Nutr. 70(2):208212.
  • Oswalt, M. L., and G. D. Marshall. 2008. Ragweed as an example of worldwide allergen expansion. Allergy Asthma Clin. Immunol. 4(3):130135.
  • Pawankar, R., S. Mori, C. Ozu, and S. Kimura. 2011. Overview on the pathomechanisms of allergic rhinitis. Asia Pac. Allergy 1(3):157167.
  • Pearson, A., A. Lux, and M. Krieger. 1995. Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 92(9):40564060.
  • Pongdee, T. Ragweed plants packed with pollen. AAAAI 2011. Available at: http://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Libraries/EL-ragweed-patient.pdf (accessed 26 January 2012).
  • Price, D. D., P. A. McGrath, A. Rafii, and B. Buckingham. 1983. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17(1):4556.
  • Ramakers, J. D., J. J. Volman, M. Biorklund, G. Onning, R. P. Mensink, and J. Plat. 2007. Fecal water from ileostomic patients consuming oat β-glucan enhances immune responses in enterocytes. Mol. Nutr. Food Res. 51(2):211220.
  • Rice, P. J., J. L. Kelley, G. Kogan, H. E. Ensley, J. H. Kalbfleisch, I. W. Browder, et al. 2002. Human monocyte scavenger receptors are pattern recognition receptors for (1–>3)-beta-D-glucans. J. Leukoc. Biol. 72(1):140146.
  • Rice, P. J., E. L. Adams, T. Ozment-Skelton, A. J. Gonzalez, M. P. Goldman, B. E. Lockhart, et al. 2005. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J. Pharmacol. Exp. Ther. 314(3):10791086.
  • Riggi, S. J., and N. R. Di Luzio. 1961. Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol. 200:297300.
  • Romagnani, S., E. Maggi, P. Parronchi, D. Macchia, M. P. Piccinni, and M. Ricci. 1991. Increased numbers of Th2-like CD4 +  T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int. Arch. Allergy Appl. Immunol. 94(1–4):133136.
  • Ross, G. D., J. A. Cain, B. L. Myones, S. L. Newman, and P. J. Lachmann. 1987. Specificity of membrane complement receptor type three (CR3) for β-glucans. Complement 4(2):6174.
  • Rylander, R., M. Norrhall, U. Engdahl, A. Tunsater, and P. G. Holt. 1998. Airways inflammation, atopy, and (1–> 3)- β -D-glucan exposures in two schools. Am. J. Respir. Crit. Care Med. 158(5 Pt 1):16851687.
  • Sarinho, E., D. Medeiros, D. Schor, S. A. Rego, V. Sales, M. E. Motta, et al. 2009. Production of interleukin-10 in asthmatic children after β-1-3-glucan. Allergol. Immunopathol. (Madr.) 37(4):188192.
  • Shah, V. B., Y. Huang, R. Keshwara, T. Ozment-Skelton, D. L. Williams, and L. Keshvara. 2008. β glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner. J. Immunol. 180(5):27772785.
  • Shimizu, K., S. Watanabe, S. Watanabe, K. Matsuda, T. Suga, S. Nakazawa, et al. 2009. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology 56(89):240244.
  • 7Suzuki, I., H. Tanaka, A. Kinoshita, S. Oikawa, M. Osawa, and T. Yadomae. 1990. Effect of orally administered b-glucan on macrophage function in mice. Int. J. Immunopharmacol. 12(6):675684.
  • Szabo, Z., M. Szilasi, L. Brugos, S. Szanto, I. Kovacs, M. Szeles, et al. 2000. Differences in the changes of allergen-specific IgE serum levels and the chemiluminescence of peripheral blood phagocytes in patients with allergic rhinoconjunctivitis during the ragweed season. Immunol. Lett. 74(3):201205.
  • Taylor, P. R., G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon, et al. 2002. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169(7):38763882.
  • Thornton, B. P., V. Vetvicka, M. Pitman, R. C. Goldman, and G. D. Ross. 1996. Analysis of the sugar specificity and molecular location of the b-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156(3):12351246.
  • Tsoni, S. V., and G. D. Brown. 2008. β-Glucans and dectin-1. Ann. N. Y. Acad. Sci. 1143:4560.
  • Tsukada, C., H. Yokoyama, C. Miyaji, Y. Ishimoto, H. Kawamura, and T. Abo. 2003. Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of β-glucan. Cell. Immunol. 221(1):15.
  • U.S. Food and Drug Administration. 2008. Agency Response Letter GRAS Notice No. GRN 000239. CFSAN. Available from: http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm153925.htm (accessed 31 January 2012).
  • Vassallo, R., J. Standing, and A. H. Limper. 1999. β-glucan from Pneumocystis carinii stimulates TNF a release from alveolar macrophages. J. Eukaryot. Microbiol. 46(5):145S.
  • Vassallo, R., J. E. Standing, and A. H. Limper. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164(7):37553763.
  • Vetvicka, V., and J. C. Yvin. 2004. Effects of marine β-1,3 glucan on immune reactions. Int. Immunopharmacol. 4(6):721730.
  • Volman, J. J., J. D. Ramakers, and J. Plat. 2008. Dietary modulation of immune function by β-glucans. Physiol. Behav. 94(2):276284.
  • Ware, J. E. Jr. 1992. Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30(6):473483.
  • Weitberg, A. B. 2008. A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy. J. Exp. Clin. Cancer Res. 27:40.
  • Willment, J. A., A. S. Marshall, D. M. Reid, D. L. Williams, S. Y. Wong, S. Gordon, et al. 2005. The human β -glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur. J. Immunol. 35(5):15391547.
  • Wooles, W. R., and N. R. Diluzio. 1963. Reticuloendothelial function and the immune response. Science 142(3595):10781080.
  • Wopfner, N., G. Gadermaier, M. Egger, R. Asero, C. Ebner, B. Jahn-Schmid, et al. 2005. The spectrum of allergens in ragweed and mugwort pollen. Int. Arch. Allergy Immunol. 138(4):337346.
  • Yamada, J., J. Hamuro, H. Hatanaka, K. Hamabata, and S. Kinoshita. 2007. Alleviation of seasonal allergic symptoms with superfine β-1,3-glucan: a randomized study. J. Allergy Clin. Immunol. 119(5):11191126.
  • Yoon, T. J., T. J. Kim, H. Lee, K. S. Shin, Y. P. Yun, W. K. Moon, et al. 2008. Anti-tumor metastatic activity of b-glucan purified from mutated Saccharomyces cerevisiae. Int. Immunopharmacol. 8(1):3642.
  • Yoshino, S., S. Watanabe, M. Imano, T. Suga, S. Nakazawa, S. Hazama, et al. 2010. Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer. Hepatogastroenterology 57(97):172177.
  • Young, M. C. 1998. Rhinitis, sinusitis, and polyposis. Allergy Asthma Proc. 19(4):211218.
  • Zanon, P., E. Chiodini, and D. Berra. 2002. Allergy to ragweed in northern Italy and prevention strategies. Monaldi Arch. Chest Dis. 57(2):144146.
  • Zhang, K., and H. R. Petty. 1994. Influence of polysaccharides on neutrophil function: specific antagonists suggest a model for cooperative saccharide-associated inhibition of immune complex-triggered superoxide production. J. Cell. Biochem. 56(2):225235.
  • Zimmerman, J. W., J. Lindermuth, P. A. Fish, G. P. Palace, T. T. Stevenson, and D. E. DeMong. 1998. A novel carbohydrate-glycosphingolipid interaction between a β-(1–3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273(34):2201422020.